Another study revealed that the CD4+ CAR T-cell subset, was more effective than CD8+ CAR T-cells in orthotopic GBM mouse models and IL-13Rα2-CAR T-cells, which possibly indicated that CD8+ CAR T-cells were rapidly exhausted (44). The gene discussed is CD8A; the disease is glioblastoma.